SunLink Health Systems Inc
SSY1.170USD
+0.130+12.50%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
8.24MMarktkapitalisierung
4.78KGV TTM
mehr Informationen über SunLink Health Systems Inc Unternehmen
SunLink Health Systems, Inc., through subsidiaries, owns and operates healthcare businesses in the Southeast. The Company’s operations are composed of a pharmacy business and an information technology (IT) business. The pharmacy business is composed of four operational areas conducted in three locations in southwest Louisiana: retail pharmacy products and services, consisting of retail pharmacy sales; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, behavioral and specialty hospitals, hospice, and correctional facilities and durable medical equipment products and services, consisting primarily of the sale and rental of products for institutional clients. Its subsidiary SunLink Health Systems Technology provides information technology (IT) services to outside customers.
Unternehmensinformationen
BörsenkürzelSSY
Name des UnternehmensSunLink Health Systems Inc
IPO-datumMar 18, 1980
CEOMr. Robert M. Thornton, Jr.
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeMar 18
AddresseSuite 1120
StadtATLANTA
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl30339
Telefon17709337000
Websitehttp://www.sunlinkhealth.com/
BörsenkürzelSSY
IPO-datumMar 18, 1980
CEOMr. Robert M. Thornton, Jr.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Steven J. Baileys
Dr. Steven J. Baileys
Independent Director
Independent Director
832.88K
--
Mr. Mark J. Stockslager
Mr. Mark J. Stockslager
Chief Financial Officer, Principal Accounting Officer, Director
Chief Financial Officer, Principal Accounting Officer, Director
108.05K
--
Ms. Sheila G. Brockman
Ms. Sheila G. Brockman
Vice President, Chairperson of Southern Health Corporation of Houston, Inc
Vice President, Chairperson of Southern Health Corporation of Houston, Inc
--
--
Mr. Eugene E. (Gene) Burleson
Mr. Eugene E. (Gene) Burleson
Independent Director
Independent Director
--
--
Mr. C. Michael Ford
Mr. C. Michael Ford
Independent Director
Independent Director
--
--
Mr. Robert M. Thornton, Jr.
Mr. Robert M. Thornton, Jr.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Byron D. Finn
Mr. Byron D. Finn
President of SunLink ScriptsRx, LLC
President of SunLink ScriptsRx, LLC
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Steven J. Baileys
Dr. Steven J. Baileys
Independent Director
Independent Director
832.88K
--
Mr. Mark J. Stockslager
Mr. Mark J. Stockslager
Chief Financial Officer, Principal Accounting Officer, Director
Chief Financial Officer, Principal Accounting Officer, Director
108.05K
--
Ms. Sheila G. Brockman
Ms. Sheila G. Brockman
Vice President, Chairperson of Southern Health Corporation of Houston, Inc
Vice President, Chairperson of Southern Health Corporation of Houston, Inc
--
--
Mr. Eugene E. (Gene) Burleson
Mr. Eugene E. (Gene) Burleson
Independent Director
Independent Director
--
--
Mr. C. Michael Ford
Mr. C. Michael Ford
Independent Director
Independent Director
--
--
Mr. Robert M. Thornton, Jr.
Mr. Robert M. Thornton, Jr.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Aug 1
Aktualisiert: Fri, Aug 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Baileys (Steven J)
11.83%
Thornton (Robert M Jr)
7.95%
Radoff (Bradley Louis)
5.04%
Radoff Family Foundation
4.45%
Renaissance Technologies LLC
3.38%
Other
67.35%
Aktionäre
Aktionäre
Anteil
Baileys (Steven J)
11.83%
Thornton (Robert M Jr)
7.95%
Radoff (Bradley Louis)
5.04%
Radoff Family Foundation
4.45%
Renaissance Technologies LLC
3.38%
Other
67.35%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
28.36%
Investment Advisor
5.05%
Family Office
4.45%
Hedge Fund
3.65%
Investment Advisor/Hedge Fund
2.58%
Venture Capital
0.19%
Other
55.72%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
29
2.80M
39.83%
-245.47K
2025Q1
28
2.79M
39.65%
-213.51K
2024Q4
27
2.63M
37.40%
+6.77K
2024Q3
28
2.77M
39.40%
-239.24K
2024Q2
28
2.78M
39.43%
-259.75K
2024Q1
27
2.87M
40.75%
-248.68K
2023Q4
29
2.94M
41.83%
-153.64K
2023Q3
29
2.99M
42.50%
-71.71K
2023Q2
30
2.97M
42.24%
+13.84K
2023Q1
32
2.92M
41.55%
-25.39K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Baileys (Steven J)
832.88K
11.83%
+40.00
+0.00%
Jun 20, 2025
Thornton (Robert M Jr)
559.56K
7.95%
--
--
Jun 20, 2025
Radoff (Bradley Louis)
354.98K
5.04%
+4.98K
+1.42%
Mar 31, 2025
Radoff Family Foundation
313.00K
4.45%
+73.00K
+30.42%
Mar 31, 2025
Renaissance Technologies LLC
238.28K
3.38%
-200.00
-0.08%
Mar 31, 2025
Stockslager (Mark J)
108.05K
1.53%
--
--
Jun 20, 2025
Acadian Asset Management LLC
102.36K
1.45%
-16.85K
-14.14%
Mar 31, 2025
Bridgeway Capital Management, LLC
95.18K
1.35%
-122.62K
-56.30%
Mar 31, 2025
Burleson (Gene E)
91.60K
1.3%
--
--
Jun 20, 2025
The Vanguard Group, Inc.
83.94K
1.19%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
